Provided by Tiger Trade Technology Pte. Ltd.

CytomX Therapeutics

4.52
+0.10002.26%
Post-market: 4.520.00000.00%19:49 EDT
Volume:7.54M
Turnover:34.39M
Market Cap:977.12M
PE:-30.13
High:4.80
Open:4.40
Low:4.37
Close:4.42
52wk High:8.21
52wk Low:0.4000
Shares:216.18M
Float Shares:113.00M
Volume Ratio:1.14
T/O Rate:6.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1500
EPS(LYR):-0.1500
ROE:-35.25%
ROA:-8.99%
PB:9.87
PE(LYR):-30.13

Loading ...

Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 25, 2023

Major Issues Report

Form 8-K - Current report
Aug 24, 2023

Correspondence

Form CORRESP - Correspondence
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jul 03, 2023

Major Issues Report

Form 8-K - Current report
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
Mar 27, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2023

Major Issues Report

8-K - Current report
Mar 27, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 24, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals